Title |
Safety of licensed vaccines in HIV-infected persons: a systematic review protocol
|
---|---|
Published in |
Systematic Reviews, September 2014
|
DOI | 10.1186/2046-4053-3-101 |
Pubmed ID | |
Authors |
Benjamin M Kagina, Charles S Wiysonge, Maia Lesosky, Shabir A Madhi, Gregory D Hussey |
Abstract |
Safety of vaccines remains a cornerstone of building public trust on the use of these cost-effective and life-saving public health interventions. In some settings, particularly Sub-Saharan Africa, there is a high prevalence of HIV infection and a high burden of vaccine-preventable diseases. There is evidence suggesting that the immunity induced by some commonly used vaccines is not durable in HIV-infected persons, and therefore, repeated vaccination may be considered to ensure optimal vaccine-induced immunity in this population. However, some vaccines, particularly the live vaccines, may be unsafe in HIV-infected persons. There is lack of evidence on the safety profile of commonly used vaccines among HIV-infected persons. We are therefore conducting a systematic review to assess the safety profile of routine vaccines administered to HIV-infected persons. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
South Africa | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 3% |
Unknown | 34 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 17% |
Student > Master | 5 | 14% |
Student > Ph. D. Student | 4 | 11% |
Student > Doctoral Student | 3 | 9% |
Student > Postgraduate | 3 | 9% |
Other | 7 | 20% |
Unknown | 7 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 8 | 23% |
Nursing and Health Professions | 7 | 20% |
Biochemistry, Genetics and Molecular Biology | 2 | 6% |
Engineering | 2 | 6% |
Agricultural and Biological Sciences | 1 | 3% |
Other | 5 | 14% |
Unknown | 10 | 29% |